Adamas Pharma Cash Flow - Quarterly (NASDAQ:ADMS)

Add to My Stocks
$25.21 $0.29 (1.14%) ADMS stock closing price Jun 22, 2018 (Closing)

The financial analysis of ADMS requires an investor to check the cash flows for Adamas Pharma. While its important to look at the Adamas Pharma debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as Adamas Pharma revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. Adamas Pharma saw a cash impact of $135.02M from the issuance of ADMS shares. The cash flow statement helps in the Adamas Pharma stock analysis by providing more information for evaluating changes in assets, liabilities and equities. Adamas Pharma saw a outflow of $-150.59M from investing activities till 2018 Q1.

View and download details of Adamas Pharma cash flows for latest & last 40 quarters
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Net Income Cash Flow
-34.97M-89.49M-60.13M-36.77M-16.02M-60.05M-45.09M-30.7M-13.82M-51.8M
Depreciation Depletion Amortization Cash-Flow-1.65M1.1M-------
Net Increase (Decrease) in Assets Liabilities1.25M3.29M5.24M2.27M-1.29M--1.35M--1.62M-6.67M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net8.59M17.71M11.78M7.37M2.88M10.57M7.78M5.18M2.55M10.83M
Net Cash from (used by) Operating Activities
-24.79M-66.82M-42M-26.62M-13.93M-48.06M-38.43M-24.51M-12.5M-47.21M
Increase (Decrease) in Prop Plant And Equipment-0.5M-1.25M-0.93M-0.62M-0.36M-1.62M-1.22M-1.24M-0.46M-1.39M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments-150.09M26.82M3.72M1.02M10.8M-25.08M-48.73M37.65M16.07M9.45M
Other Cash Inflow (Outflow) from Investment Activities----------
Net Cash from (used by) Investment Activities
-150.59M25.56M2.79M-10.44M-26.7M-49.95M36.4M15.61M8.05M
Issuance (Purchase) of Equity Shares135.02M9.11M3.19M1.2M-64.78M64.74M63.94M62.19M10.4M
Issuance (Repayment) of Debt Securities-99.6M34.6M34.6M------
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities---0.19M-------
Net Cash from (used by) Financing Activities
135.02M108.84M37.59M36.09M-65.4M65.06M64.27M62.19M10.81M
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
-40.37M67.58M-1.61M9.88M-2.81M-9.36M-23.32M76.16M65.3M-28.34M
Cash & Equivalents at Beginning of Year23.73M33.1M61.44M85.61M62.95M3.11M----
Cash & Equivalents at Year End50.94M91.31M22.12M33.61M20.91M23.73M9.77M109.27M98.4M33.1M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

While Adamas Pharma stock price history provides the price history of a stock, Adamas Pharma stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:

  • Adamas Pharma has cash of $50.94M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the Adamas Pharma stock price.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a negative value of $-24.79M for ADMS.
  • Cash from investing stood at a negative value of $-150.59M for ADMS stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. Adamas Pharma earned $135.02M from financing activities,in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For Adamas Pharma Cash Flow

Quarterly Cash Flow Statements For Adamas Pharmaceuticals Inc Peers

Acadia Pharma cash flow, Amphastar Pharma cash flow, Cymabay cash flow, GlaxoSmithKline cash flow, Merck cash flow